Chronic Inflammatory Demyelinating Polyneuropathy: Current Therapies and Emerging Horizons

In this MEDtalk, Anders Svenningsson, MD, PhD, Professor at the Karolinska Institute in Sweden, discusses current treatment strategies for chronic inflammatory demyelinating polyneuropathy (CIDP), with considerations for both younger and older patient populations. He also shares his perspective on emerging therapies and offers insights into the future direction of CIDP management.